Jan 13, 2020 | biosimilars, health policy, oncology, oncopolicy |
last december, the canadian institute for health information published statistics on drug spending, finding that in 2018 approximately 40% of drug spending was spent on 2% of beneficiaries. of this 2%, three out of five individuals used a drug therapy that cost...
